Web NewDrugInformation.com

Temovate Drug - Temovate The trade name of the product as shown on the labeling. Dosage - SOLUTION; TOPICAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Clobetasol Propionate Multiple ingredients are in alphabetical order. Strength - 0.05% The potency of the active ingredient(s), Clobetasol Propionate. May repeat for multiple part products. Applicant - ALTANA The firm name holding legal responsibility for Temovate. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 019966 The FDA assigned number to Temovate. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Temovate. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - AT The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Feb 22, 1990 The date Temovate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - Yes The pioneer or innovator of Temovate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Temovate is in. Format is RX, OTC, DISCN. Applicant Full Name - Altana Inc The full name of the firm holding legal responsibility for the new application of Temovate. Temovate Clobetasol Propionate 0.05% Solution; Topical Clobetasol Propionate 0.05% Solution; Topical Embeline 0.05% Solution; Topical Temovate 0.05% Solution; Topical Temovate 0.05% Ointment; Topical Clobex 0.05% Shampoo; Topical Clobetasol Propionate 0.05% Solution; Topical Clobetasol Propionate 0.05% Solution; Topical Clobetasol Propionate 0.05% Solution; Topical Clobetasol Propionate 0.05% Solution; Topical NewDrugInformation